Loading clinical trials...
Loading clinical trials...
A Prospective, Randomized, Open Label Study To Compare The Efficacy, Safety And Tolerability Of 17-B Estradiol/Trimegestone CC 1 Mg (Totelle) And Tibolone (Livial) In Postmenopausal Women.
Conditions
Interventions
17B Estradiol (1mg) / (0.125 mg) TMG Continuous combined (Totelle)
Tibolone (Livial)
Locations
1
Mexico
Pfizer Investigational Site
Monterrey, Nuevo León, Mexico
Start Date
February 1, 2006
Primary Completion Date
December 1, 2009
Completion Date
December 1, 2009
Last Updated
October 29, 2010
NCT07022925
NCT07229404
NCT03541200
NCT02907983
NCT02865538
NCT05300568
Lead Sponsor
Wyeth is now a wholly owned subsidiary of Pfizer
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions